KOLON TISSUEGENE INC has a total of 23 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2003. It filed its patents most often in Australia, United States and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are TISSUEGENE INC, ABRAHAM J AND PHYLLIS KATZ CORD BLOOD FOUND and JENNEREX INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 10 | |
#2 | United States | 5 | |
#3 | Republic of Korea | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Medical technology | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Object sterilising | |
#6 | Analysing materials | |
#7 | Enzymes | |
#8 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Lee Kwan Hee | 20 |
#2 | Noh Moon Jong | 17 |
#3 | Yi Youngsuk | 11 |
#4 | Bae Hyun | 6 |
#5 | Kang Sung Woo | 5 |
#6 | Kim Hyoung Chun | 3 |
#7 | Noh Moon | 3 |
#8 | Song Sun Uk | 3 |
#9 | Lee Kwan | 3 |
#10 | Lee Duk Keun | 3 |
Publication | Filing date | Title |
---|---|---|
WO2020205720A2 | Mixed-cell gene therapy | |
WO2020205730A1 | Treatment of intervertebral disc degeneration | |
WO2020205717A1 | CARTILAGE REGENERATION USING CHONDROCYTE AND TGF-β | |
US2019224248A1 | Cartilage regeneration using chondrocyte and tgf-beta | |
AU2006261889A1 | Neuroprotective effective compound |